More Healthcare Coverage

  • March 05, 2024

    Magnolia Medical Again Sues Kurin Over Sepsis IP

    Magnolia Medical has accused Kurin of continuing to infringe patents covering its diagnostic tests for sepsis and other bloodstream infections after Kurin lost a jury trial in 2022 over a different patent, claiming its rival has a "predatory business model."

  • March 05, 2024

    Conn. Healthcare Trade Group Drops Staffing Rule Challenge

    A healthcare trade group has dropped its suit seeking to stop Connecticut health officials from implementing new nursing home staff allocation controls in the wake of a new law increasing per-patient staffing hours.

  • March 05, 2024

    Avadel Told To Pay Jazz Pharma $234K Over Narcolepsy Drug IP

    A Delaware federal jury found Monday that a specialty drugmaker owes nearly $234,000 to drug manufacturer Jazz Pharmaceuticals Inc. for using a patented process behind its newer narcolepsy drug, launched last year to sales of over $28 million.

  • March 05, 2024

    FDA Rejection Of Fosamax's Label Fix Not Final, 3rd Circ. Told

    Counsel for patients suing Merck over its osteoporosis drug Fosamax's alleged risk of causing painful bone fractures told a Third Circuit panel Tuesday that a Food and Drug Administration letter denying changes to the drug's label does not count as a final agency action triggering federal preemption of state law failure to warn claims.

  • March 05, 2024

    NJ Atty Aims To Duck Claims He Botched Suit Amid Pandemic

    A New Jersey attorney has asked a state court to dismiss a former client's legal malpractice claims against him arising out of the confusion of the onset of the COVID-19 pandemic, arguing that the allegations show "duplicity" in repudiating an underlying medical malpractice settlement he negotiated for her.

  • March 05, 2024

    Ex-Walgreens CLO Joins UnitedHealth In Advisory Role

    Walgreens' former top legal leader in the U.S. and a one-time O'Melveny & Myers LLP healthcare partner has announced on her LinkedIn profile that she has joined UnitedHealth Group Inc. as an "executive in residence" to help advise its management team.

  • March 04, 2024

    DLA Piper Snags Temporary Block Of Docs Order In Sale Spat

    A Texas appellate court has agreed to block a trial court's order that would have forced DLA Piper to hand over communications with a medical group it represented in a sale, tentatively finding the firm will either prevail in its challenge or that a "serious question" requires further consideration.

  • March 04, 2024

    Tobacco Cos. Urge DC Circ. To Ax Broad Health Warning Order

    Tobacco giants R.J. Reynolds and ITG Brands have backed a bid to overturn a D.C. district court order classifying Philip Morris USA's electronic tobacco devices, called HeatSticks, as "cigarettes," thereby subjecting them to the same marketing requirements that warn consumers of the negative health effects of smoking.

  • March 04, 2024

    Elanco Urges Justices To Preserve Junk Fax Win

    Pet medicine company Elanco Animal Health Inc. has told the U.S. Supreme Court that its faxed invitations to a veterinarian seminar don't count under the Telephone Consumer Protection Act's prohibition on unsolicited fax advertisements, as the Seventh Circuit ruled in July.

  • March 04, 2024

    Insurer Wants Trade Secret Suit Dropped Sans Atty Fee Award

    A dental health insurer asked a Washington federal judge on Monday to toss its trade secret claims against an ex-executive without leeway for her to request legal fees, arguing that she can't be considered a winning party because she handed over a company laptop after being hit with the suit.

  • March 01, 2024

    Adamas' Ex-COO Agrees To $4.6M Deal In Investor Suit

    Adamas Pharmaceutical Inc. investors asked a California federal judge on Friday to approve a $4.65 million settlement with the company's former chief operating officer to resolve proposed class claims the company misled consumers about the success of its treatment for Parkinson's disease.

  • March 01, 2024

    Aetna Can't Escape Fertility Bias Suit From Same-Sex Couple

    A California federal judge has declined to toss a woman's case challenging Aetna's fertility treatment coverage as discriminatory, finding at this stage, she has sufficiently argued that the policy discriminates against LGBTQ couples in violation of the Affordable Care Act.

  • March 01, 2024

    Pa. Supreme Court Snapshot: Judge's Side Gig Vexes Tax Row

    In its first argument session of 2024, the Supreme Court of Pennsylvania will once again have seven justices on the bench to hear cases concerning issues like a judge taking a second job, following last year's elevation of Superior Court Judge Daniel D. McCaffery to fill the vacancy left by the death of former Chief Justice Max Baer in 2022.

  • March 01, 2024

    GSK, Shook Hardy Can Recover Costs After Zofran MDL Win

    GlaxoSmithKline and its attorneys from Shook Hardy & Bacon LLP can recover more than $450,000 in legal costs after beating a multidistrict suit claiming the company's anti-nausea drug Zofran caused birth defects, a federal judge has ruled.

  • March 01, 2024

    Auto Coverage Hinges On Victim's Domicile, Mich. Panel Says

    A dispute over personal protection insurance will return to a trial court to determine whether a crash victim was residing in Michigan or Kentucky at the time of the incident, after a Michigan state appeals court granted neither the victim's guardian nor Progressive an early win.

  • March 01, 2024

    Gilead, Cipla Ink Deal To End HIV Drug Buyers' Antitrust Suit

    Gilead Sciences Inc. and generics maker Cipla told a California federal judge Friday they've reached a settlement ending a proposed class action filed by a public employees' health insurance fund over an alleged anti-competitive patent deal to delay the launch of a generic version of the HIV drug Truvada.

  • March 01, 2024

    UW Settles Missing Tumor Suit After Admitting It Can't Find It

    The University of Washington has settled a medical malpractice lawsuit accusing its hospital staff of losing a tumor before testing it for cancer, after UW admitted that it had been "unable to locate the specimen" since the patient's August 2022 surgery.

  • February 28, 2024

    7th Circ. Revives Health System Worker's FMLA Suit For Trial

    A split Seventh Circuit panel on Wednesday revived a former OSF Healthcare System employee's suit accusing the company of wrongfully firing her after failing to adjust performance expectations while she worked reduced hours, ruling a factual dispute remains over how much leave she took, which could lead a jury to find in her favor.

  • February 28, 2024

    Ga. Panel Brings Doctor In, Publix Out In Drug Allergy Case

    The Georgia Court of Appeals on Wednesday overturned a trial court ruling releasing a doctor from the professional malpractice suit of a patient who was hospitalized for nearly two weeks following an allergic reaction to a prescription drug but remained "unpersuaded" that Publix Super Markets Inc. was liable in the case.

  • February 28, 2024

    4 Firms Plan To Co-Lead Suboxone Dental Decay MDL

    Attorneys from Peiffer Wolf Carr Kane Conway & Wise LLP and three other law firms have asked an Ohio federal judge to appoint them co-lead counsel for the new multidistrict litigation over opioid addiction treatment Suboxone allegedly causing dental decay, with 14 other firms seeking appointment to plaintiff leadership committees.

  • February 28, 2024

    Nurse Wants Staff Co. Wage Suit Paused For 11th Circ. Appeal

    A nurse asked a Georgia federal judge to stay her proposed class action alleging a staffing firm lured nurses to work in Florida using unfulfilled wage promises, pending her appeal of a ruling denying her bid for class certification.

  • February 27, 2024

    Conn. Agency Asks Judge To Rethink Tuition Refund Pause

    The Connecticut Office of Higher Education has asked a state judge to vacate a ruling that paused the agency's refund process for students affected by the abrupt shutdown of Stone Academy, arguing the judge shouldn't have exercised jurisdiction over the matter and that the ruling interferes with the agency's statutory authority to implement the program.

  • February 27, 2024

    Troubled REIT Finds Lifeline In $941M Bond Offering

    Diversified Healthcare Trust, which doubted its ability to survive mounting debt issues last year, no longer faces an existential threat due to proceeds it netted from a $941 million senior secured notes offering, an executive of the real estate investment trust said.

  • February 26, 2024

    Sales Reps Score $1.6M In Fees After Beating RICO Case

    A federal judge in Los Angeles has ordered a biotech startup to pay more than $1.6 million in legal fees to two former employees, after the company failed to convince a jury that the pair broke racketeering laws when they worked for a rival that stole proprietary information when setting up shop.

  • February 26, 2024

    Medical Device Companies Settle Ga. Wrongful Death Suit

    Two medical alert device companies have settled a Georgia man's allegations that their negligent handling of his mother's distress call led to her death, avoiding a looming trial in the case, according to a filing Monday in Peach State federal court.

Expert Analysis

  • New Mich. Cannabis Policy May Lower Costs For Some Cos.

    Author Photo

    Under a recently issued bulletin from Michigan’s cannabis regulator, certain growers and processors may be able to significantly reduce costs by shifting the balance of their medical and adult-use licenses — but this strategy does entail some complications, says Robert Hendricks at Warner Norcross.

  • No Surprises Act Gives Plan Sponsors Savings Opportunities

    Author Photo

    Under the No Surprises Act, the potential savings for an ERISA group health plan and its participants are significant, and sponsors should focus on the negotiation of third-party administrator service agreements to avoid exposure to breach of fiduciary claims for payment of excessive fees, say attorneys at Hall Benefits.

  • Cos. Need Clarity On Divergent FCA Pleading Standard

    Author Photo

    With the U.S. Supreme Court’s recent denial of certiorari in three cases concerning False Claims Act pleading standards, potential FCA defendants remain subject to forum shopping, greater prosecutorial scrutiny in more lenient circuits and ambiguity that makes crafting multijurisdictional compliance policies nearly impossible, say attorneys at Troutman Pepper.

  • Time Is Ticking For Callers To Address Complex TCPA Rules

    Author Photo

    The recently published Telephone Consumer Protection Act amendments will be effective in July, giving previously exempt entities only a short time to comply with technical and onerous requirements for prerecorded, nonmarketing calls to landlines, say attorneys at Wiley.

  • What Cannabis Cos. Must Know About Strict Product Liability

    Author Photo

    To evaluate the traditional product liability risks of their products, cannabis companies should understand the common tests used by courts to determine strict liability, as well as how marijuana consumers are educated about product risks, says Ian Stewart at Wilson Elser.

  • FCA Knowledge Element: NY Already Got It Right

    Author Photo

    In April, when the U.S. Supreme Court hears arguments in U.S. v. Supervalu and U.S. v. Safeway concerning the federal False Claims Act's knowledge component, it should consider the reasoning of a New York state court ruling that already reached the correct understanding, says Randall Fox at Kirby McInerney.

  • Evaluating Workplace Accommodations For Service Animals

    Author Photo

    In Bennett v. Hurley Medical Center, a Michigan federal court ruled in favor of the hospital after a nursing intern filed a disability discrimination lawsuit regarding her service dog, highlighting the importance of engaging in interactive processes and individualized actions in workplace accommodation decisions, say Keith Anderson and Anne Yuengert at Bradley Arant.

  • Fla. Bill Would Rein In Personal Injury Litigation Excesses

    Author Photo

    A recently proposed bill in the Florida House that would change bad-faith laws and the admissibility of medical bills for services performed under a letter of protection would provide reasonable checks on practices that are far too common in personal injury cases in the Sunshine State, say attorneys at Baker Donelson.

  • Bankruptcy Ruling Affirms High 9th Circ. Evidentiary Standard

    Author Photo

    The Ninth Circuit Bankruptcy Appellate Panel's recent ruling in Groves demonstrates that Section 363 — which allows a debtor-in-possession to sell their property in order to generate cash — fails as a tool when it’s used to turn a nondebtor entities' property into property of a debtor's bankruptcy estate, says Brian Shaw at Cozen O'Connor.

  • Absent Federal Action, Tribal Cannabis Laws Remain In Limbo

    Author Photo

    Many Native American tribes have proceeded with cannabis legalization efforts despite inconsistent federal enforcement and a confusing jurisdictional landscape, but until the federal government takes action, tribal sovereignty on this issue will remain ad-hoc and uncertain, says Anna Wills at Duane Morris.

  • J&J Ch. 11 Dismissal Ignores Mass Tort Bankruptcy Principles

    Author Photo

    The Third Circuit's recent dismissal of LTL Management's Chapter 11 petition due to insufficient financial distress — even as the Johnson & Johnson subsidiary defends thousands of tort claims — runs contrary to decades of precedent in mass tort bankruptcies, says Douglas Smith at Aurelius Law.

  • Don't Assume AI Is Smart Enough To Avoid Unintended Bias

    Author Photo

    As companies increasingly incorporate artificial intelligence decision models into their business practices, they should consider using statistical and qualitative analyses to evaluate and reduce inadvertent discrimination, or disparate impact, induced by AI, say Christine Polek and Shastri Sandy at The Brattle Group.

  • Circuit Split Complicates US Discovery In Foreign Tribunals

    Author Photo

    Differences between the Second and Fourth Circuits' interpretations of when litigants in foreign tribunals may obtain discovery in U.S. courts are substantial, making companies' decisions about where to file a Section 1782 application complex, say attorneys at Finnegan.

Can't find the article you're looking for? Click here to search the Healthcare Authority Other archive.